Your browser doesn't support javascript.
loading
Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology.
Ide, Masayuki; Ohnishi, Tetsuo; Toyoshima, Manabu; Balan, Shabeesh; Maekawa, Motoko; Shimamoto-Mitsuyama, Chie; Iwayama, Yoshimi; Ohba, Hisako; Watanabe, Akiko; Ishii, Takashi; Shibuya, Norihiro; Kimura, Yuka; Hisano, Yasuko; Murata, Yui; Hara, Tomonori; Morikawa, Momo; Hashimoto, Kenji; Nozaki, Yayoi; Toyota, Tomoko; Wada, Yuina; Tanaka, Yosuke; Kato, Tadafumi; Nishi, Akinori; Fujisawa, Shigeyoshi; Okano, Hideyuki; Itokawa, Masanari; Hirokawa, Nobutaka; Kunii, Yasuto; Kakita, Akiyoshi; Yabe, Hirooki; Iwamoto, Kazuya; Meno, Kohji; Katagiri, Takuya; Dean, Brian; Uchida, Kazuhiko; Kimura, Hideo; Yoshikawa, Takeo.
Affiliation
  • Ide M; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Ohnishi T; Department of Psychiatry, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Toyoshima M; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Balan S; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Maekawa M; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Shimamoto-Mitsuyama C; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Iwayama Y; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Ohba H; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Watanabe A; Support Unit for Bio-Material Analysis, Research Division, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Ishii T; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Shibuya N; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Kimura Y; Research& Development Department, MCBI Inc, Tsukuba, Ibaraki, Japan.
  • Hisano Y; Department of Pharmacology, Sanyo-Onoda City University, Sanyo-Onoda, Yamaguchi, Japan.
  • Murata Y; Department of Molecular Pharmacology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
  • Hara T; Department of Pharmacology, Sanyo-Onoda City University, Sanyo-Onoda, Yamaguchi, Japan.
  • Morikawa M; Department of Molecular Pharmacology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
  • Hashimoto K; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Nozaki Y; Department of Molecular Brain Science, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Toyota T; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Wada Y; Department of Organ Anatomy, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Tanaka Y; Department of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kato T; Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan.
  • Nishi A; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Fujisawa S; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Okano H; Laboratory of Molecular Psychiatry, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Itokawa M; Graduate School of Humanities and Sciences, Ochanomizu University, Tokyo, Japan.
  • Hirokawa N; Department of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kunii Y; Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Kakita A; Department of Pharmacology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
  • Yabe H; Laboratory for Systems Neurophysiology, RIKEN Center for Brain Science, Wako, Saitama, Japan.
  • Iwamoto K; Department of Physiology, Keio University School of Medicine, Tokyo, Japan.
  • Meno K; Center for Medical Cooperation, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Katagiri T; Department of Cell Biology and Anatomy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Dean B; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan.
  • Uchida K; Department of Psychiatry, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu, Fukushima, Japan.
  • Kimura H; Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Yoshikawa T; Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan.
EMBO Mol Med ; 11(12): e10695, 2019 12.
Article in En | MEDLINE | ID: mdl-31657521
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Sulfides / Hydrogen Sulfide Limits: Animals Language: En Journal: EMBO Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2019 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Sulfides / Hydrogen Sulfide Limits: Animals Language: En Journal: EMBO Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2019 Type: Article Affiliation country: Japan